These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36401156)

  • 21. Policies and measures implemented to reduce the impact of international sanctions on Iran's pharmaceutical sector.
    Emami F; Cheraghali AM
    Res Pharm Sci; 2022 Jun; 17(3):274-283. PubMed ID: 35531135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of the Sanctions Made Against Iran on Availability to Asthma Medicines in Tehran.
    Ghiasi G; Rashidian A; Kebriaeezadeh A; Salamzadeh J
    Iran J Pharm Res; 2016; 15(3):567-571. PubMed ID: 27980593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 management in Iran and international sanctions.
    Pormasoumi H; Rostami D; Jamebozorgi K; Mirshekarpour H; Heshmatnia J
    Eur J Transl Myol; 2022 Oct; 32(4):. PubMed ID: 36200579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of United States political sanctions on international collaborations and research in Iran.
    Kokabisaghi F; Miller AC; Bashar FR; Salesi M; Zarchi AAK; Keramatfar A; Pourhoseingholi MA; Amini H; Vahedian-Azimi A
    BMJ Glob Health; 2019; 4(5):e001692. PubMed ID: 31544001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Sanctions and the Procurement of Medical Equipment in Iran: A Qualitative Study.
    Azami SR; Hosseini SM; Alimohammadzadeh K; Jafari M; Bahadori MK
    Med J Islam Repub Iran; 2021; 35():180. PubMed ID: 35706524
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse Impacts of Imposing International Economic Sanctions on Health.
    Asgardoon MH; Amirzade-Iranaq MH; Mehri A; Piri SM; Jalali P; Ghodsi Z; Dehghan HR; Rahimi-Movaghar V; Salamati P
    Arch Iran Med; 2022 Mar; 25(3):182-190. PubMed ID: 35429961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How the US Sanctions Are Affecting the Health Research System in Iran?
    Dehghani M; Mesgarpour B; Akhondzadeh S; Azami-Aghdash S; Ferdousi R
    Arch Iran Med; 2021 Feb; 24(2):101-106. PubMed ID: 33636976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Provision of Peace and Right to Health through Sanctions: Threats and Opportunities.
    Dastafkan R; Salehi H; Hooshmand MM
    Arch Iran Med; 2020 Apr; 23(4Suppl1):S43-S48. PubMed ID: 32349508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Service quality in Iranian hospitals: A systematic review and meta-analysis.
    Rezaei S; Hajizadeh M; Zandian H; Fathi A; Nouri B
    Med J Islam Repub Iran; 2018; 32():59. PubMed ID: 30175085
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug adherence of patients with epilepsy in Iran: the effects of the international economic sanctions.
    Asadi-Pooya AA; Tavana B; Tavana B; Emami M
    Acta Neurol Belg; 2016 Jun; 116(2):151-5. PubMed ID: 26442685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of pharmaceutical policies in response to economic crises and sanctions.
    Kheirandish M; Rashidian A; Kebriaeezade A; Cheraghali AM; Soleymani F
    J Res Pharm Pract; 2015; 4(3):115-22. PubMed ID: 26312250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Social determinants of health inequity in Iran: a narrative review.
    Rezaei N; Moghaddam SS; Farzadfar F; Larijani B
    J Diabetes Metab Disord; 2023 Jun; 22(1):5-12. PubMed ID: 36373156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer research in Iran: a scientometric analysis of publications output from 1991 to 2015 in Scopus.
    Zarei M; Bagheri-Saweh MI; Rasolabadi M; Vakili R; Seidi J; Kalhor MM; Etaee F; Gharib A
    Electron Physician; 2017 Feb; 9(2):3816-3822. PubMed ID: 28465812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies to improve pharmaceutical supply chain resilience under politico-economic sanctions: the case of Iran.
    Bastani P; Dehghan Z; Kashfi SM; Dorosti H; Mohammadpour M; Mehralian G; Ravangard R
    J Pharm Policy Pract; 2021 Jul; 14(1):56. PubMed ID: 34225794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. U.S.-Imposed Economic Sanctions on Iran in the COVID-19 Crisis From the Human Rights Perspective.
    Karimi A; Turkamani HS
    Int J Health Serv; 2021 Oct; 51(4):570-572. PubMed ID: 34106781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cross-impact between financial markets, Covid-19 pandemic, and economic sanctions: The case of Iran.
    Samadi AH; Owjimehr S; Nezhad Halafi Z
    J Policy Model; 2021; 43(1):34-55. PubMed ID: 32994651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to sanction international wrongdoing? The design of EU restrictive measures.
    Meissner K
    Rev Int Organ; 2023; 18(1):61-85. PubMed ID: 36593909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical assessment of progress of medical sciences in Iran and Turkey: the way developing countries with limited resources should make effective contributions to the production of science.
    Massarrat S; Kolahdoozan S
    Arch Iran Med; 2011 Nov; 14(6):370-7. PubMed ID: 22039839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Providing a framework for assessment of the access to medicine.
    Afzali M; Khorasani E; Alvandi M; Sabbagh-Bani-Azad M; Sharif Z; Saiyarsarai P; Nikfar S
    Daru; 2019 Jun; 27(1):243-254. PubMed ID: 31055777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iranian Herbal Medicines Against Hydatid Cyst Protoscoleces: A Systematic Review.
    Salimikia I; Hakami M; Shahmoradi MK
    Infect Disord Drug Targets; 2021; 21(5):e270421188119. PubMed ID: 33208081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.